DVAX
NASDAQDynavax Technologies Corporation
Price$15.49+5.44 (+54.18%)
2025-11-042026-02-09
News · 26 weeks550%
2025-11-092026-05-03
Mix3890d
- SEC Filings23(61%)
- Insider13(34%)
- Other2(5%)
Latest news
25 items- SECSEC Form 15-12G filed by Dynavax Technologies Corporation15-12G - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
- SECSEC Form EFFECT filed by Dynavax Technologies CorporationEFFECT - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
- INSIDERSEC Form 4 filed by Large owner Deep Track Biotechnology Master Fund, Ltd.4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Issuer)
- SECSEC Form S-8 POS filed by Dynavax Technologies CorporationS-8 POS - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
- SECSEC Form S-8 POS filed by Dynavax Technologies CorporationS-8 POS - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
- SECSEC Form S-8 POS filed by Dynavax Technologies CorporationS-8 POS - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
- SECSEC Form S-8 POS filed by Dynavax Technologies CorporationS-8 POS - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
- SECSEC Form S-8 POS filed by Dynavax Technologies CorporationS-8 POS - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
- SECSEC Form S-8 POS filed by Dynavax Technologies CorporationS-8 POS - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
- SECSEC Form S-8 POS filed by Dynavax Technologies CorporationS-8 POS - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
- SECSEC Form S-8 POS filed by Dynavax Technologies CorporationS-8 POS - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
- SECSEC Form S-8 POS filed by Dynavax Technologies CorporationS-8 POS - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
- INSIDERDirector Emini Emilio returned 10,075 units of Common Stock - Restricted Stock Units to the company, closing all direct ownership in the company (SEC Form 4)4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Issuer)
- INSIDERDirector Myers Scott Dunseth returned 31,204 units of Common Stock - Restricted Stock Units to the company, closing all direct ownership in the company (SEC Form 4)4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Issuer)
- INSIDERVP, Chief Accounting Officer Metzinger Joseph Anthony closing all direct ownership in the company (SEC Form 4)4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Issuer)
- SECSEC Form S-8 POS filed by Dynavax Technologies CorporationS-8 POS - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
- INSIDERDirector Kisner Daniel L returned 21,829 units of Common Stock - Restricted Stock Units to the company, closing all direct ownership in the company (SEC Form 4)4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Issuer)
- INSIDERSVP and CFO Macdonald Kelly was granted 88,854 units of Common Stock - Performance Stock Units and returned 88,854 units of Common Stock - Performance Stock Units to the company, closing all direct ownership in the company (SEC Form 4)4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Issuer)
- INSIDERDirector Sun Elaine D returned 29,865 units of Common Stock - Restricted Stock Units to the company, closing all direct ownership in the company (SEC Form 4)4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Issuer)
- INSIDERCEO and Director Spencer Ryan was granted 301,000 units of Common Stock - Performance Stock Units and returned 301,000 units of Common Stock - Performance Stock Units to the company, closing all direct ownership in the company (SEC Form 4)4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Issuer)
- INSIDERSVP General Counsel Slebir John L was granted 92,424 units of Common Stock - Performance Stock Units and returned 92,424 units of Common Stock - Performance Stock Units to the company, closing all direct ownership in the company (SEC Form 4)4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Issuer)
- SECSEC Form S-8 POS filed by Dynavax Technologies CorporationS-8 POS - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
- INSIDERDirector Silvernail Lauren P returned 10,075 units of Common Stock - Restricted Stock Units to the company, closing all direct ownership in the company (SEC Form 4)4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Issuer)
- INSIDERDirector Cano Francis returned 42,663 units of Common Stock - Restricted Stock Units to the company, closing all direct ownership in the company (SEC Form 4)4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Issuer)
- INSIDERDirector Macgregor Brent returned 21,829 units of Common Stock - Restricted Stock Units to the company, closing all direct ownership in the company (SEC Form 4)4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Issuer)
DVAX FAQ
7 questionsWhat does Dynavax Technologies Corporation do?
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp &...Where does DVAX stock trade?
Dynavax Technologies Corporation (DVAX) is listed on NASDAQ.What sector and industry is DVAX in?
Dynavax Technologies Corporation operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Dynavax Technologies Corporation go public?
Dynavax Technologies Corporation (DVAX) completed its IPO in 2004.What are analysts saying about DVAX?
Dynavax Technologies Corporation has had 8 recent analyst actions on file. The most recent action was from Goldman: Sell with a $1200.00 price target on 2025-02-11. Recent price targets range from $1200.00 to $3800.00.What companies are similar to DVAX?
Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), NVS (Novartis AG). Compare DVAX side-by-side with any of them on Quantisnow.How can I track DVAX on Quantisnow?
Quantisnow aggregates Dynavax Technologies Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow DVAX to receive live email and push alerts on every new disclosure.